Golidocitinib Versus Placebo as Maintenance Therapy in PTCL Patients With Response (CR/PR) After First-Line Chemotherapy
Clinical trial NCT07414758 · RECRUITING
Trial details
- NCT number
- NCT07414758
- Sponsor
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-15
- Primary completion
- 2028-09-30
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.